Insider Transactions in Q3 2025 at Taysha Gene Therapies, Inc. (TSHA)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 10
2025
|
Sukumar Nagendran President and Head of R&D |
SELL
Open market or private sale
|
Direct |
200,000
-16.58%
|
$600,000
$3.23 P/Share
|
|
Sep 10
2025
|
Sukumar Nagendran President and Head of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
41,150
+3.3%
|
$0
$0.7 P/Share
|
|
Aug 21
2025
|
Kamran Alam CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
54,491
-4.39%
|
$108,982
$2.85 P/Share
|
|
Aug 21
2025
|
Sukumar Nagendran President and Head of R&D |
SELL
Open market or private sale
|
Direct |
57,054
-4.67%
|
$114,108
$2.85 P/Share
|